Monday, 5 October 2026European Markets

SELECTIRENTE And 3 Other Stocks Have Very High Payout Ratio

Loading stream...

(VIANEWS) - SPBK1 RINGERIKE (RING.OL), SELECTIRENTE (SELER.PA), CORTICEIRA AMORIM (COR.LS) are the highest payout ratio stocks on this list.

Here's the data we've collected of stocks with a high payout ratio up to now. The payout ratio in itself isn't a promise of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. SPBK1 RINGERIKE (RING.OL)

103.63% Payout Ratio

SpareBank 1 Ringerike Hadeland provides various banking products and services to private and corporate customers in Norway. The company offers saving, current, deposit, and currency accounts; vehicle, house and travel, and animal insurance products, as well as life, child, disability, critical illness, accident, health, and business and personal insurance products; mobile and online banking services; and debit and credit cards. It also provides mortgages; car, boat, and other vehicles; consumer and other loans; and bank guarantees, corporate and construction loans, liquidity loans with a government guarantee, and operating credit for agriculture, as well as factoring, leasing, and overdraft services. In addition, the company offers services for buying and selling property; accounting services; pension products; and savings and investment products. The company was founded in 1833 and is based in Hønefoss, Norway.

Earnings Per Share

As for profitability, SPBK1 RINGERIKE has a trailing twelve months EPS of kr22.77.

PE Ratio

SPBK1 RINGERIKE has a trailing twelve months price to earnings ratio of 14.58. Meaning, the purchaser of the share is investing kr14.58 for every norwegian krone of annual earnings.

Volume

Today's last reported volume for SPBK1 RINGERIKE is 125 which is 91.07% below its average volume of 1400.

Moving Average

SPBK1 RINGERIKE's value is above its 50-day moving average of kr329.32 and higher than its 200-day moving average of kr324.29.

2. SELECTIRENTE (SELER.PA)

64.75% Payout Ratio

Selectirente is a public real estate fund managed by Sofidy. It invests in city center and suburb commercial properties, which should be located close to shopping malls. It primarily acquires properties in France. As of March 29, 2019, Selectirente operates as a subsidiary of Tikehau Capital.

Earnings Per Share

As for profitability, SELECTIRENTE has a trailing twelve months EPS of €2.62.

PE Ratio

SELECTIRENTE has a trailing twelve months price to earnings ratio of 38.21. Meaning, the purchaser of the share is investing €38.21 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.59%.

3. CORTICEIRA AMORIM (COR.LS)

46.88% Payout Ratio

Corticeira Amorim, S.G.P.S., S.A. manufactures and sells cork and cork related products worldwide. The company operates through Raw Materials, Cork Stoppers, Floor and Wall Coverings, Composite Cork, and Insulation Cork segments. It offers cork raw materials; cork stoppers for sparkling wine, spirit, beer, and cider industries; and cork wall and floor coverings. The company also provides cork composite solutions to use in various applications, such as aerospace, mobility, energy, sealing, construction, sports surfaces, flooring, home, office and leisure goods, footwear, panels, and composites. In addition, it offers insulation cork materials to use in sustainable insulation/construction, and interior and exterior designing. The company was founded in 1870 and is headquartered in Mozelos, Portugal.

Earnings Per Share

As for profitability, CORTICEIRA AMORIM has a trailing twelve months EPS of €0.48.

PE Ratio

CORTICEIRA AMORIM has a trailing twelve months price to earnings ratio of 20.12. Meaning, the purchaser of the share is investing €20.12 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.44%.

4. SPAREBANK 1 SR-BK (SRBNK.OL)

46.58% Payout Ratio

SpareBank 1 SR-Bank ASA, together with its subsidiaries, provides various financial products and services for personal and corporate customers in Southern and Western Norway. The company offers its products and services in the areas of savings, loans, advice, insurance, and pensions. It also provides foreign exchange, administrative securities, commercial properties, leasing, accounting, estate agency, payroll/HR, and securities trading services, as well as management and securities management services. In addition, the company facilitates debt and equity funding; and sells real estate properties comprising holiday homes, new builds, and used homes. Further, it is involved in the customer trading of interest rate instruments; and purchasing of home mortgages. Additionally, the company offers green loan; credit and debit cards; consulting; and mobile and online banking services. The company also serves retail and corporate, small business, and agricultural customers, as well as the public sector. SpareBank 1 SR-Bank ASA was founded in 1839 and is headquartered in Stavanger, Norway.

Earnings Per Share

As for profitability, SPAREBANK 1 SR-BK has a trailing twelve months EPS of kr6.22.

PE Ratio

SPAREBANK 1 SR-BK has a trailing twelve months price to earnings ratio of 20.8. Meaning, the purchaser of the share is investing kr20.8 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.05%.

Moving Average

SPAREBANK 1 SR-BK's worth is above its 50-day moving average of kr118.95 and way higher than its 200-day moving average of kr113.53.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com